| Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness Yasmin, S Wallace, CM McEniery, Z Dakham, P Pusalkar, K Maki-Petaja, ... Arteriosclerosis, thrombosis, and vascular biology 25 (2), 372-378, 2005 | 598 | 2005 |
| Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti–tumor necrosis factor-α therapy KM Mäki-Petäjä, FC Hall, AD Booth, SML Wallace, Yasmin, ... Circulation 114 (11), 1185-1192, 2006 | 547 | 2006 |
| Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction SML Wallace, Yasmin, CM McEniery, KM Maki-Petaja, AD Booth, ... Hypertension 50 (1), 228-233, 2007 | 380 | 2007 |
| Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis KM Mäki-Petäjä, AD Booth, FC Hall, SML Wallace, J Brown, CM McEniery, ... Journal of the American College of Cardiology 50 (9), 852-858, 2007 | 340 | 2007 |
| Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults CM McEniery, Yasmin, S Wallace, K Maki-Petaja, B McDonnell, ... Hypertension 46 (1), 221-226, 2005 | 314 | 2005 |
| Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals CM McEniery, BJ McDonnell, A So, S Aitken, CE Bolton, M Munnery, ... Hypertension 53 (3), 524-531, 2009 | 267 | 2009 |
| Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis KM Mäki-Petäjä, M Elkhawad, J Cheriyan, FR Joshi, AJK Östör, FC Hall, ... Circulation 126 (21), 2473-2480, 2012 | 248 | 2012 |
| Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals Yasmin, CM McEniery, KM O’Shaughnessy, P Harnett, A Arshad, ... Arteriosclerosis, thrombosis, and vascular biology 26 (8), 1799-1805, 2006 | 161 | 2006 |
| A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical … AK Annamalai, A Webb, N Kandasamy, M Elkhawad, S Moir, F Khan, ... The Journal of Clinical Endocrinology & Metabolism 98 (3), 1040-1050, 2013 | 158 | 2013 |
| Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial PR Gajendragadkar, A Hubsch, KM Mäki-Petäjä, M Serg, IB Wilkinson, ... PloS one 9 (6), e99070, 2014 | 154 | 2014 |
| The impact of cardiovascular risk factors on aortic stiffness and wave reflections depends on age: the Anglo-Cardiff Collaborative Trial (ACCT III) CM McEniery, null Yasmin, KM Maki-Petaja, BJ McDonnell, M Munnery, ... Hypertension 56 (4), 591-597, 2010 | 143 | 2010 |
| Inhibition of p38 mitogen-activated protein kinase improves nitric oxide–mediated vasodilatation and reduces inflammation in hypercholesterolemia J Cheriyan, AJ Webb, L Sarov-Blat, M Elkhawad, SML Wallace, ... Circulation 123 (5), 515-523, 2011 | 131 | 2011 |
| Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans IS Mackenzie, KM Maki-Petaja, CM McEniery, YP Bao, SM Wallace, ... Arteriosclerosis, thrombosis, and vascular biology 25 (9), 1891-1895, 2005 | 126 | 2005 |
| Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society L Zanoli, M Briet, JP Empana, PG Cunha, KM Mäki-Petäjä, AD Protogerou, ... Journal of hypertension 38 (9), 1682-1698, 2020 | 120 | 2020 |
| Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease M Fisk, PR Gajendragadkar, KM Mäki-Petäjä, IB Wilkinson, J Cheriyan American Journal of Cardiovascular Drugs 14, 155-165, 2014 | 107 | 2014 |
| Prevention of cardiovascular disease in rheumatoid arthritis I Hollan, PH Dessein, N Ronda, MC Wasko, E Svenungsson, S Agewall, ... Autoimmunity reviews 14 (10), 952-969, 2015 | 102 | 2015 |
| Anti-inflammatory drugs and statins for arterial stiffness reduction KM Maki-Petaja, IB Wilkinson Current pharmaceutical design 15 (3), 290-303, 2009 | 90 | 2009 |
| The role of epoxyeicosatrienoic acids in the cardiovascular system L Yang, K Mäki‐Petäjä, J Cheriyan, C McEniery, IB Wilkinson British journal of clinical pharmacology 80 (1), 28-44, 2015 | 78 | 2015 |
| Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction KM Mäki-Petäjä, J Cheriyan, AD Booth, FC Hall, J Brown, SML Wallace, ... International journal of cardiology 129 (3), 399-405, 2008 | 74 | 2008 |
| Uses of arterial stiffness in clinical practice IB Wilkinson, KM Mäki-Petäjä, GF Mitchell Arteriosclerosis, thrombosis, and vascular biology 40 (5), 1063-1067, 2020 | 73 | 2020 |
Parag GajendragadkarConsultant Cardiologist and ElectrophysiologistVerified email at nhs.net
